Pharmacy procurement now sits at the intersection of financial performance, supply chain and regulatory accountability. As margins tighten and shortages persist, leaders can no longer rely on isolated purchasing decisions to protect their organizations.

This report outlines a clearer path forward. It shows how procurement can evolve into a strategic capability that supports smarter financial decisions, stronger supply continuity and continuous 340B readiness.

The report draws on real-world examples to demonstrate what this shift looks like in practice, including documented cost savings, proactive shortage planning and comprehensive transaction auditing. It also details how modern procurement technology enables the insights needed to manage these priorities together, rather than in conflict.

Key takeaways include: